<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04794595</url>
  </required_header>
  <id_info>
    <org_study_id>fdpicu-08</org_study_id>
    <nct_id>NCT04794595</nct_id>
  </id_info>
  <brief_title>Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children</brief_title>
  <official_title>Clinical Features and Outcomes of Continuous Blood Purification Versus Non-continuous Blood Purification in Pediatric Patients With Sepsis or Septic Shock</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Children's Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital of Fudan University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of continuous blood purification (CBP) in children is unclear. Also, the timing of&#xD;
      early application is still being explored. In this study, we need to explore the efficacy and&#xD;
      the timing of application of CBP in children with sepsis or septic shock.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Early intervention of CBP can remove inflammatory factors in patients with sepsis and reduce&#xD;
      the damage of inflammatory factors to organs; at the same time, it can also promote the&#xD;
      body's immune response, significantly improve immune dysfunction, and restore the body's&#xD;
      immune balance. However, the timing of early application of CBP in childhood sepsis is still&#xD;
      unclear. Therefore, it is necessary to further explore the treatment and prognosis of this&#xD;
      technology in the early treatment of sepsis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2018</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>survival rate</measure>
    <time_frame>28 days after hospital discharge</time_frame>
    <description>The survival rate of children in 28 days after hospital discharge</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The creatinine level of non-survival children with sepsis</measure>
    <time_frame>28 days after hospital discharge</time_frame>
    <description>The creatinine level of non-survival children with sepsis in 28 days after hospital discharge</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Sepsis</condition>
  <condition>Children, Only</condition>
  <arm_group>
    <arm_group_label>sepsis group with CBP</arm_group_label>
    <description>The child with sepsis should be treated with CBPï¼Œ but could not receive this treatment for various reasons</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sepsis group without CBP</arm_group_label>
    <description>The child with sepsis should be treated with CBP and received this treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CBP</intervention_name>
    <description>continuous blood purification can prevent or treat fluid overload in children with septic shock or other sepsis-associated organ dysfunction who are unresponsive to fluid restriction and diuretic therapy management of septic AKI patients, particularly those with hemodynamic instability or fluid overload. Also, it can remove cytokines</description>
    <arm_group_label>sepsis group with CBP</arm_group_label>
    <other_name>traditional therapy</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      the volume of 2ml whole blood was stored in EDTA tube&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        children with sepsis requiring blood purification to prevent or treat fluid overload or to&#xD;
        clear cytokines&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age of 29d to 18 years old;&#xD;
&#xD;
          -  Children diagnosed with sepsis requiring blood purification.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  with a history of a duration of PICU stay &lt;24 h&#xD;
&#xD;
          -  active bleeding, including cerebral hemorrhage&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lu guoing</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>YING JIAYUN</last_name>
    <phone>18817583962</phone>
    <email>jiayundoctor@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Children'S Hospital of Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>201102</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>YING JIAYUN</last_name>
      <phone>18817583962</phone>
      <email>jiayundoctor@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 9, 2021</study_first_submitted>
  <study_first_submitted_qc>March 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2021</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Continuous renal replacement therapy</keyword>
  <keyword>sepsis</keyword>
  <keyword>timing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

